title: Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.
authors.affiliation: Cardiovascular Institute, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden. Jacob.Odenstedet@vgregion.se
authors.forename: Jacob
authors.initials: J
authors.lastname: Odenstedt
authors.forename: Chrichan
authors.initials: C
authors.lastname: Månsson
authors.forename: Lars
authors.initials: L
authors.lastname: Grip
mesh_terms: D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004195:Disease Models, Animal; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D011725:Pyridines / Q000494:pharmacology*; D013552:Swine; D014693:Ventricular Fibrillation / Q000503:physiopathology
chemical_list: D002121:Calcium Channel Blockers; D011725:Pyridines; C118563:clevidipine